AIM2-driven inflammasome activation in heart failure
Abstract Aims Interleukin-1β (IL-1β) is an important pathogenic factor in cardiovascular diseases including chronic heart failure (HF). The CANTOS trial highlighted that inflammasomes as primary sources of IL-1 β are promising new therapeutic targets in cardiovascular diseases. Therefore, we aimed t...
Saved in:
| Published in: | Cardiovascular research Vol. 117; no. 13; pp. 2639 - 2651 |
|---|---|
| Main Authors: | , , , , , , , , , , , , , , , , , , , |
| Format: | Journal Article |
| Language: | English |
| Published: |
England
Oxford University Press
22.11.2021
|
| Subjects: | |
| ISSN: | 0008-6363, 1755-3245, 1755-3245 |
| Online Access: | Get full text |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!